Showing results (2041-2050 of 6,887) with videos related to
Sort By:
Pageof 689
Leukemia Research|January 1, 1990
Potentiation of glucocorticoid-induced cytolysis in sensitive human leukemic cells by an inhibitor of ADP-ribosylationA S Meyer, J A Schlechte, T J SchmidtLeukemia Research|December 18, 2010
A small molecule significantly inhibits the bcr/abl fusion gene at the mRNA level in human chronic myelogenous leukemiaQun He, Jun Dong, Huanying Zhen, et al.Leukemia Research|April 13, 2010
The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cellsMaika Almstedt, Nadja Blagitko-Dorfs, Jesús Duque-Afonso, et al.Leukemia Research|June 18, 2010
Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemiaMaria Kraj, Joanna Kopeć-Szlęzak, Ryszard Pogłód, et al.Leukemia Research|July 22, 2010
17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cellsJennifer M Napper, Vincent E SollarsLeukemia Research|August 20, 2010
Alloreactive natural killer cells in hematopoietic stem cell transplantationHollie J Pegram, David S Ritchie, Mark J Smyth, et al.Leukemia Research|July 10, 2010
Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromesPeter L Greenberg, Charles A Koller, Z Ioav Cabantchik, et al.Leukemia Research|July 8, 2010
Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily aloneFranck E Nicolini, Sandrine Hayette, Laurence Legros, et al.Leukemia Research|August 7, 2010
Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndromeIrene Mavroudi, Katerina Pyrovolaki, Konstantia Pavlaki, et al.Leukemia Research|August 7, 2010
Relationship of serum imatinib trough level and response in CML patients: long term follow-upAbdalla Awidi, Ayed O Ayed, Nazzal Bsoul, et al.Pageof 689